The Myths About MIPS

著者: Quest Diagnostics
  • サマリー

  • Together to explore the myths about participating in the Merit-Based incentive Payment System by sharing our experience and helping you understand the difference between what is fact and what is fiction, so you can decide what help or support is right for your medical practice.
    Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks—®' and ™'—are the property of their respective owners. © 2000-2022 Quest Diagnostics Incorporated. All rights reserved.
    続きを読む 一部表示

あらすじ・解説

Together to explore the myths about participating in the Merit-Based incentive Payment System by sharing our experience and helping you understand the difference between what is fact and what is fiction, so you can decide what help or support is right for your medical practice.
Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks—®' and ™'—are the property of their respective owners. © 2000-2022 Quest Diagnostics Incorporated. All rights reserved.
エピソード
  • Myth 4 - Commercial payers, claims and EHRs don’t matter
    2021/11/29

    MIPS is a Quality Payment Program payment track that determines how Eligible Medicare providers get reimbursed.  But can participating in this program be affected by other aspects of a medical practice that aren’t related to Medicare?  Our team of experts break down whether or not third-party payers have any impact on how practices perform in MIPS.  They also ascertain what, if any, truth there is to how claims data might be relevant to performance and what differences Electronic Health Record technology makes in achieving successful outcomes.

    Important points of view discussed are:

    • What claims data and EHR data have in common with MIPS
    • Whether or not one methodology of collecting data for MIPS is better than another
    • If and when does patients’ insurance make a difference in MIPS performance and reimbursement

    This episode features Quest Quality Consulting experts, Erika Krivenko, Julia Zieger, and Carrie Shepard

    続きを読む 一部表示
    33 分
  • Myth 3 - MIPS doesn‘t affect the bottom line
    2021/11/29

    You don’t want to miss the Quest Quality Improvement experts dialogue about the cost of participating or not participating in MIPS.  They examine when it may or may not be economically beneficial to participate in MIPS and discuss the time/value of participating to achieve the optimum results.  Together, they explore examples of when a practice may return sizable gains by participating effectively and what hurdles and setbacks practices might expect by not managing their performance well.  There may be a cost to participating in the MIPS program, but in this episode, they take a closer look at when that cost might actually be a return on investment.

    Important points of view discussed are:

    • The cost/reward of effective and ineffective time management
    • How a MIPS score can actually affect the reimbursement cost/benefit to a practice
    • When patient satisfaction plays into MIPS performance for greater reward

    This episode features Quest Quality Consulting experts, Erika Krivenko, Julia Zieger, and Carrie Shepard.

    続きを読む 一部表示
    24 分
  • Myth 2 - MIPS is going away in 2021
    2021/07/30

    "MIPS is going away” is an ongoing rumor among healthcare professionals following the tumultuous year 2020 hurled at us. Today’s podcast examines why MIPS is such a burden and causes so many different dilemmas in healthcare.  We scrutinize how the federal budget, legislation, the growing number of Medicare beneficiaries and growing number of reduced resources are confounding a system already in disarray. We address the common -that it would be easier to get rid of a program that causes so much confusion and seems to benefit so few.

     

    Important points of view discussed are:

    • The increase in the number of patients eligible for Medicare
    • Legislation setting the standards for performance
    • The correlation between performance and monetary resources available to eligible clinicians
    • Why investing in strong performance in MIPS will be a value in the future

     

    This episode features Quest Quality Consulting experts, Erika Krivenko, Julia Zieger and Carrie Shepard

    続きを読む 一部表示
    27 分

The Myths About MIPSに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。